New York City, July 14, 2020 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE:BETR) (OTCQB:BETRD) (FRA: BLife Therapeutics BLife TherapeuticsNPAT) indicated the...
New York City, July 06, 2020 (GLOBE NEWSWIRE) -- The CEO of BetterLife Pharma (OTCQB:BETRD) (CSE: BETR) (FRANKFURT: NPAT), an emerging clinical stage pharmaceutical development company, recently...
New York, June 30, 2020 (GLOBE NEWSWIRE) -- BetterLife Pharma (OTCQB:BETRD) (CSE: BETR) (FRANKFURT: NPAT), an emerging clinical stage pharmaceutical development company, believe that a...
New York City, June 19, 2020 (GLOBE NEWSWIRE) -- BetterLife Pharma (OTCQB:BETRF) (CSE: BETR) (FRANKFURT: NPAT), an emerging clinical stage pharmaceutical development company, announced recently...
期間 † | 前日比 | 前日比 % | 始値 | 高値 | 安値 | 平均出来高 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0.105 | 0.11 | 0.1 | 37389 | 0.10307947 | CS |
4 | 0 | 0 | 0.105 | 0.12 | 0.1 | 45196 | 0.10520729 | CS |
12 | -0.015 | -12.5 | 0.12 | 0.13 | 0.1 | 31551 | 0.11112791 | CS |
26 | -0.07 | -40 | 0.175 | 0.195 | 0.09 | 44556 | 0.12908975 | CS |
52 | -0.005 | -4.54545454545 | 0.11 | 0.195 | 0.07 | 66979 | 0.11400906 | CS |
156 | -0.115 | -52.2727272727 | 0.22 | 0.305 | 0.05 | 75180 | 0.12610708 | CS |
260 | -0.025 | -19.2307692308 | 0.13 | 2.9 | 0.04 | 91033 | 0.32570472 | CS |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約